Jazz Pharmaceuticals: all 223 studies
Page 2 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver DiseaseCompletedNCT01284634Phase 2Results posted
- Sativex® for Relieving Persistent Pain in Participants With Advanced CancerCompletedNCT01262651Phase 3Results posted
- Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus DiseaseCompletedNCT01241344Phase 2Results posted
- GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesCompletedNCT01217112Phase 2Results posted
- Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA VirusesCompletedNCT01143181Phase 3Results posted
- Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant RecipientsCompletedNCT00942305Phase 2Results posted
- Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)CompletedNCT00822094Phase 2Results posted
- Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With FibromyalgiaCompletedNCT00803023Phase 3Results posted
- CMX001 in Post-transplant Patients With BK Virus ViruriaCompletedNCT00793598Phase 1/2Results posted
- Trial of CPX-351 in Newly Diagnosed Elderly AML PatientsCompletedNCT00788892Phase 2Results posted
- A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic PainCompletedNCT00713817Phase 3Results posted
- A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.CompletedNCT00713323Phase 3Results posted
- A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.CompletedNCT00711880Phase 3Results posted
- A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.CompletedNCT00711646Phase 3Results posted
- A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With AllodyniaCompletedNCT00710554Phase 3Results posted
- A Study of Sativex® for Pain Relief Due to Diabetic NeuropathyCompletedNCT00710424Phase 3Results posted
- Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple SclerosisCompletedNCT00702468Phase 3Results posted
- A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)CompletedNCT00681538Phase 3Results posted
- A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple SclerosisCompletedNCT00678795Phase 3Results posted
- Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related PainCompletedNCT00675948Phase 3Results posted
- A Study of Sativex® for Pain Relief in Patients With Advanced MalignancyCompletedNCT00674609Phase 3Results posted
- Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND StudyCompletedNCT00628498Phase 3Results posted
- Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential TremorCompletedNCT00598078Phase 2Results posted
- Study of Intranasal Clonazepam in Adult Subjects With Epileptic SeizuresCompletedNCT00594945Phase 2Results posted
- A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.CompletedNCT00530764Phase 2Results posted
- A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPDTerminatedNCT00457951Phase 2Results posted
- A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.CompletedNCT00423813Phase 3Results posted
- Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.CompletedNCT00423605Phase 3Results posted
- Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MSCompletedNCT00391079Phase 3Results posted
- A Safety and Efficacy Study of Xyrem® in Subjects With FibromyalgiaCompletedNCT00371137Phase 3Results posted
- Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal CancerCompletedNCT00361842Phase 2Results posted
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant PatientsCompletedNCT00358501Phase 3Results posted
- Trial of Xyrem® (Sodium Oxybate) for the Treatment of NarcolepsyCompletedNCT00132873Phase 3Results posted
- Experimental Medication For the Treatment of Generalized Anxiety DisorderCompletedNCT00097708Phase 3Results posted
- Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of FibromyalgiaCompletedNCT00087555Phase 2Results posted
- Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea PatientsCompletedNCT00086281Phase 4Results posted
- Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in NarcolepsyCompletedNCT00066170Phase 3Results posted
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy ParticipantsActive, not recruitingNCT07377539Phase 1
- A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1TerminatedNCT06961266Phase 1
- VYxeoS Liposomal Italian Observational Study iN the Real PracticeCompletedNCT06143839
- A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis ComplexCompletedNCT05864846Phase 4
- Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life SettingActive, not recruitingNCT05772429
- A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum DisorderWithdrawnNCT05733390Phase 2
- A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy ParticipantsCompletedNCT05720494Phase 1
- A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy ParticipantsCompletedNCT05651152Phase 1
- A JZP341 Study in Adult Participants With Advanced or Metastatic Solid TumorsTerminatedNCT05631327Phase 1
- A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Active, not recruitingNCT05557045Phase 1
- Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALYActive, not recruitingNCT05485831
- Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine GliomasNo longer availableNCT05392374
- Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy SubjectsCompletedNCT05391724Phase 1
- CPX-351 Real-World Effectiveness and Safety StudyCompletedNCT05169307
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersActive, not recruitingNCT05152147Phase 3
- Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionActive, not recruitingNCT05044819Phase 4
- A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing CancerCompletedNCT05027139Phase 1/2
- JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived AsparaginaseApproved for marketingNCT04943952
- Child and Adolescent Registry for Participants With NarcolepsyStatus unknownNCT04899947
- To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)CompletedNCT04894591
- A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in NarcolepsyCompletedNCT04803786
- Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline GliomasApproved for marketingNCT04617002
- Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress DisorderWithdrawnNCT04592159Phase 2/3
- An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract CancerNo longer availableNCT04578444
- A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USAApproved for marketingNCT04291937
- Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant RecipientsCompletedNCT04285788
- An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of EbolaWithdrawnNCT04268966Phase 2
- Investigation of Cognitive Outcomes With Cannabidiol Oral SolutionWithdrawnNCT04133480Phase 4
- A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid LeukemiaCompletedNCT04075747Phase 1
- A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AMLCompletedNCT04038437Phase 1
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedNCT03929666Phase 2
- Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum DisorderTerminatedNCT03849456Phase 2
- A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
- Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus ViremiaWithdrawnNCT03532035Phase 2
- A Post-Marketing Observational Study of VYXEOS™CompletedNCT03526926
- A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's DiseaseWithdrawnNCT03436953Phase 2
- ONC201 in Pediatric H3 K27M GliomasTerminatedNCT03416530Phase 1
- Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade GliomasNo longer availableNCT03134131
- European VOD RegistryCompletedNCT03032016
- Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersCompletedNCT02892123Phase 1
- A Web-based Observational Study of Patient-reported Outcomes in Adults With NarcolepsyCompletedNCT02769780
- An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607904Phase 2
- A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With EpilepsyCompletedNCT02607891Phase 2
- Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or DiseaseNo longer availableNCT02596997
- EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AMLApproved for marketingNCT02533115
- A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced CancerWithdrawnNCT02432612Phase 1
- A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304TerminatedNCT02420080
- A Study of GWP42006 in People With Focal Seizures - Part ACompletedNCT02369471Phase 2
- A Study of GWP42006 in People With Focal Seizures - Part BCompletedNCT02365610Phase 2
- A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.WithdrawnNCT02325024Phase 1
- An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.CompletedNCT02325011Phase 1
- An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus DiseaseWithdrawnNCT02271347Phase 2
- Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic ImpairmentWithdrawnNCT02269579Phase 2
- A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy SubjectsTerminatedNCT02240160Phase 1
- TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBMCompletedNCT02202993Phase 1
- The Chimerix CMX001 RegistryTerminatedNCT02167685
- An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)WithdrawnNCT02150928Phase 2
- An Observational Post-Marketing Safety Registry of Sativex®CompletedNCT02073474
- A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 DiabetesCompletedNCT02053272Phase 2
- A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced CancerWithdrawnNCT02038699Phase 1/2
- A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisTerminatedNCT01975688Phase 1
- A Study of the Safety and Tolerability of GWP42006 in Healthy SubjectsCompletedNCT01918735Phase 1
- A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 YearsCompletedNCT01898520Phase 3